Pregnancy and Postpartum CGM in GDM
NCT: NCT07174245 · RECRUITING
Brief Summary
Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.
Frequently Asked Questions
What is Pregnancy and Postpartum CGM in GDM?
Pregnancy and Postpartum CGM in GDM is a clinical trial registered under NCT07174245. Current status: RECRUITING.
What is the status of NCT07174245?
The current status of NCT07174245 (Pregnancy and Postpartum CGM in GDM) is: RECRUITING.
When did Pregnancy and Postpartum CGM in GDM start?
Pregnancy and Postpartum CGM in GDM started on 2025-08-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.